Finance Watch: Structure Launches Third And Largest US Biopharma IPO Of 2023
First Two, Genelux And Cadrenal, Grossed Just $22m Combined
Public Company Edition: Structure Therapeutics’ upsized initial public offering raises $161.1m, surpassing proposed terms for up to $134.3m. Also, Pliant capitalizes on good data with a $287.5m follow-on offering, while Magenta seeks strategic alternatives and Instil reveals more job cuts.
